GREY:TSTIF - Post by User
Post by
desl198on May 13, 2014 10:35pm
266 Views
Post# 22558458
re: What Differentiates TSO3
re: What Differentiates TSO3 Hopefully FDA will see the competitive diffirence. Here is the extract from page 2 of ressearch from last year :
"Our diligence still shows us that 125L+ compares favourably to peer devices (principally J&J’s Sterrad hydrogen peroxide gas plasma system and Steris’ hydrogen peroxide AMSCO V-PRO system, but also ETO systems sold by 3M and Steris, and Getinge’s HS66 steam-formaldehyde platform) on sterilant gas safety/toxicity, biomaterials compatibility, capacity/load factor dimensions, and cycle time flexibility (even though TSO3 recently decided to initially seek FDA approval for a single sterilization cycle time to expedite review), so our positive view on 125L+ commercial potential once FDA-approved is unwavering."
https://www.byroncapitalmarkets.com/wp-content/uploads/2013/07/TSO3-Inc.-Note-07-02-13.pdff